In the past week, ZJYL stock has gone up by 34.64%, with a monthly decline of -7.27% and a quarterly plunge of -63.86%. The volatility ratio for the week is 14.99%, and the volatility levels for the last 30 days are 15.35% for Jin Medical International Ltd The simple moving average for the past 20 days is 17.74% for ZJYL’s stock, with a -63.74% simple moving average for the past 200 days.
Is It Worth Investing in Jin Medical International Ltd (NASDAQ: ZJYL) Right Now?
The price-to-earnings ratio for Jin Medical International Ltd (NASDAQ: ZJYL) is 6.36x, which is above its average ratio. Moreover, the 36-month beta value for ZJYL is 13.82.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ZJYL is 37.82M and currently, short sellers hold a 1.66% of that float. On December 26, 2024, ZJYL’s average trading volume was 332.96K shares.
ZJYL) stock’s latest price update
The stock price of Jin Medical International Ltd (NASDAQ: ZJYL) has jumped by 8.89 compared to previous close of 0.90. Despite this, the company has seen a gain of 34.64% in its stock price over the last five trading days. globenewswire.com reported 2024-10-10 that Chuzhou City, China, Oct. 10, 2024 (GLOBE NEWSWIRE) — JIN MEDICAL INTERNATIONAL LTD. (the “Company” or “JinMed”) (NASDAQ: ZJYL), an industrial leader in Assistive Technologies (“AT”), and a manufacturer and developer of wheelchairs and living aids products, today announced the initiation of construction of JinMed’s new manufacturing facility at Chuzhou City, Anhui Province, China. JinMed (Anhui) Co., Ltd., a newly established subsidiary of JinMed, will be designated to operate the Chuzhou JinMed plant (the “New Facility”) which is established as an internationally standardized, innovative, and high-end wheelchair and electric wheelchair manufacturing factory. With higher-level production lines in place, more innovative high-quality products are expected to strengthen JinMed’s leadership in the AT industry.
ZJYL Trading at -30.96% from the 50-Day Moving Average
After a stumble in the market that brought ZJYL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -94.10% of loss for the given period.
Volatility was left at 15.35%, however, over the last 30 days, the volatility rate increased by 14.99%, as shares surge +3.44% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -61.42% lower at present.
During the last 5 trading sessions, ZJYL rose by +34.25%, which changed the moving average for the period of 200-days by -85.76% in comparison to the 20-day moving average, which settled at $0.8322. In addition, Jin Medical International Ltd saw -92.07% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ZJYL
Current profitability levels for the company are sitting at:
- 0.12 for the present operating margin
- 0.35 for the gross margin
The net margin for Jin Medical International Ltd stands at 0.14. The total capital return value is set at 0.11. Equity return is now at value 11.67, with 8.05 for asset returns.
Based on Jin Medical International Ltd (ZJYL), the company’s capital structure generated 0.27 points at debt to capital in total, while cash flow to debt ratio is standing at 0.06.
Currently, EBITDA for the company is 3.09 million with net debt to EBITDA at 0.32. When we switch over and look at the enterprise to sales, we see a ratio of 6.2. The receivables turnover for the company is 4.63for trailing twelve months and the total asset turnover is 0.61. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.58.
Conclusion
To wrap up, the performance of Jin Medical International Ltd (ZJYL) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
